Diatron Group

Diatron is a portfolio company of The Riverside Company, a global private equity firm focused on acquiring growing businesses valued at up to $200 million (€200 million in Europe). Founded in 1988, Riverside’s international portfolio now includes 80 companies, and it has more than $3 billion/€2.5 billion in assets under management.

Diatron is a portfolio company of The Riverside Company, a global private equity firm focused on acquiring growing businesses valued at up to $200 million (€200 million in Europe). Founded in 1988, Riverside’s international portfolio now includes 80 companies, and it has more than $3 billion/€2.5 billion in assets under management.

Diatron’s vision since the company’s foundation in 1989, is to become a worldwide leader in-vitro diagnostics, providing customers with a broad portfolio of high-quality tailored solutions. In its new production facility in Budapest, Hungary, the extensive R&D/Engineering team develops and manufactures compact hematology and clinical chemistry analyzers and reagents for the human medical and veterinary markets.

Contact Diatron Group

Diatron Science Div. 14100 S.W. 136th Street, Miami FL 33186 USA

Website link